Jefferies Group LLC Incyte Corp Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Incyte Corp stock. As of the latest transaction made, Jefferies Group LLC holds 100,000 shares of INCY stock, worth $6.88 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

100,000

Previous 10,900 817.43%

Holding current value

$6.88 Million

Previous $828,000 704.83%

% of portfolio

0.07%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Sep 21, 2023	BUY	$66.18 - $82.86 $893,430 - $1.12 Million	13,500 Added 15.61%	100,000 $6.66 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $6.56 Million - $8.21 Million	99,116 Added 1515.54%	105,656 $6.66 Million
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $5.29 Million - $6.65 Million	-79,960 Reduced 92.44%	6,540 $17,000
Q1 2022 Sep 21, 2023	BUY	$66.02 - $79.71 $5.67 Million - $6.85 Million	85,956 Added 15800.74%	86,500 $6.87 Million
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $5.63 Million - $6.79 Million	85,215 Added 6631.52%	86,500 $6.87 Million
Q4 2021 Sep 21, 2023	SELL	$63.34 - $74.11 $5.48 Million - $6.41 Million	-86,441 Reduced 99.37%	544 $39,000
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $5.43 Million - $6.35 Million	-85,700 Reduced 98.52%	1,285 $65,000
Q3 2021 Sep 21, 2023	BUY	$68.67 - $84.02 $9,270 - $11,342	135 Added 0.16%	86,985 $5.98 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $9,270 - $11,342	135 Added 0.16%	86,985 $5.98 Million
Q2 2021 Sep 21, 2023	BUY	$79.87 - $87.53 $6 Million - $6.57 Million	75,100 Added 639.15%	86,850 $7.31 Million
Q2 2021 Aug 16, 2021	BUY	$79.87 - $87.53 $6 Million - $6.57 Million	75,100 Added 639.15%	86,850 $7.31 Million
Q1 2021 Sep 21, 2023	SELL	$76.02 - $100.5 $609,528 - $805,809	-8,018 Reduced 40.56%	11,750 $954,000
Q1 2021 May 14, 2021	SELL	$76.02 - $100.5 $609,528 - $805,809	-8,018 Reduced 40.56%	11,750 $955,000
Q4 2020 Sep 21, 2023	SELL	$80.74 - $97.7 $6.93 Million - $8.39 Million	-85,888 Reduced 81.29%	19,768 $1.72 Million
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $1.28 Million - $1.55 Million	15,834 Added 402.49%	19,768 $1.72 Million
Q3 2020 Nov 13, 2020	BUY	$85.07 - $109.69 $64,483 - $83,145	758 Added 23.87%	3,934 $353,000
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $3.88 Million - $5.7 Million	-52,363 Reduced 94.28%	3,176 $330,000
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $222,077 - $302,184	-3,515 Reduced 5.95%	55,539 $4.07 Million
Q4 2019 Feb 13, 2020	BUY	$73.04 - $95.72 $886,121 - $1.16 Million	12,132 Added 25.86%	59,054 $5.16 Million
Q3 2019 Nov 13, 2019	BUY	$72.82 - $86.52 $1.93 Million - $2.29 Million	26,503 Added 129.8%	46,922 $3.48 Million
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $447,075 - $539,384	-6,081 Reduced 22.95%	20,419 $1.74 Million
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $233,519 - $323,936	-3,674 Reduced 12.18%	26,500 $2.28 Million
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $101,439 - $121,275	1,734 Added 6.1%	30,174 $1.92 Million
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $1.29 Million - $1.55 Million	20,816 Added 273.03%	28,440 $1.97 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $432,217 - $596,509	7,103 Added 1363.34%	7,624 $511,000
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $4.99 Million - $6.07 Million	-60,074 Reduced 99.14%	521 $43,000
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $3.01 Million - $3.75 Million	32,174 Added 113.21%	60,595 $5.74 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $3.1 Million - $3.93 Million	28,421	28,421 $3.32 Million

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account

Jefferies Group LLC Incyte Corp Transaction History